Lexicon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LXRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	4,410,021	1.21%
General Public	83,345,711	22.9%
Institutions	100,322,884	27.6%
VC/PE Firms	175,099,384	48.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
48.2%	Artal Group S.A.	175,099,384	US$189.2m	0%	5.57%
10.5%	FMR LLC	38,134,521	US$41.2m	10.4%	no data
2.76%	BlackRock, Inc.	10,013,007	US$10.8m	-3.1%	no data
2.63%	The Vanguard Group, Inc.	9,557,175	US$10.3m	-3.28%	no data
2.26%	Schonfeld Strategic Advisors LLC	8,212,993	US$8.9m	8.66%	0.06%
1.5%	The Invus Group, LLC	5,451,204	US$5.9m	0%	66.61%
1.02%	Geode Capital Management, LLC	3,689,271	US$4.0m	4.77%	no data
0.78%	GSA Capital Partners LLP	2,830,659	US$3.1m	251%	0.24%
0.72%	State Street Global Advisors, Inc.	2,607,574	US$2.8m	-4.07%	no data
0.62%	CIBC Private Wealth Advisors, Inc.	2,240,000	US$2.4m	0%	no data
0.58%	UBS Asset Management AG	2,095,340	US$2.3m	102%	no data
0.39%	Ikarian Capital, LLC	1,417,952	US$1.5m	-8.52%	0.51%
0.38%	Raymond Debbane	1,385,689	US$1.5m	2.73%	no data
0.32%	Charles Schwab Investment Management, Inc.	1,150,771	US$1.2m	0%	no data
0.32%	Tang Capital Management, LLC	1,150,268	US$1.2m	35.3%	0.06%
0.31%	AQR Capital Management, LLC	1,143,039	US$1.2m	0%	no data
0.31%	Northern Trust Global Investments	1,109,887	US$1.2m	-15.2%	no data
0.27%	Susquehanna International Group, LLP, Asset Management Arm	974,847	US$1.1m	77%	no data
0.22%	Lonnel Coats	798,068	US$862.5k	-27.3%	no data
0.22%	Hennion & Walsh Asset Management, Inc.	793,400	US$857.4k	-4.42%	0.04%
0.17%	Morgan Stanley, Investment Banking and Brokerage Investments	632,890	US$683.9k	22.8%	no data
0.16%	BBR Partners, LLC	570,000	US$616.0k	21.3%	0.04%
0.15%	Monaco Asset Management S.A.M.	531,600	US$574.5k	-27.6%	0.21%
0.13%	Nantahala Capital Management, LLC	460,850	US$498.0k	-93%	0.03%
0.13%	Boothbay Fund Management, LLC	454,891	US$491.6k	-5.39%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/08/10 21:01
End of Day Share Price	2025/08/08 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lexicon Pharmaceuticals, Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yigal Nochomovitz	Citigroup Inc
Kevin Kedra	G. Research, LLC
Joseph Pantginis	H.C. Wainwright & Co.